Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Oct 16;13(1):17538.
doi: 10.1038/s41598-023-44704-4.

The association of lipid metabolism and sarcopenia among older patients: a cross-sectional study

Affiliations

The association of lipid metabolism and sarcopenia among older patients: a cross-sectional study

Yiwen Jiang et al. Sci Rep. .

Abstract

Sarcopenia has become a heavy disease burden among the elderly. Lipid metabolism was reported to be involved in many degenerative diseases. This study aims to investigate the association between dysregulated lipid metabolism and sarcopenia in geriatric inpatients. This cross-sectional study included 303 patients aged ≥ 60, of which 151 were diagnosed with sarcopenia. The level of total cholesterol (TC), triglyceride (TG), high-density lipoprotein (HDL), low-density lipoprotein (LDL), homocysteine (HCY), BMI, and fat percentage, were compared between sarcopenia and non-sarcopenia patients. The Spearman correlation coefficient was used to estimate the association between sarcopenia and the level of lipid metabolism. To determine risk factors related to sarcopenia, a multivariate logistic regression analysis was carried out. Risk prediction models were constructed based on all possible data through principal component analysis (PCA), Logistic Regression (LR), Support Vector Machine (SVM), k-Nearest Neighbor (KNN), and eXtreme Gradient Boosting (XGboost). We observed rising prevalence of sarcopenia with increasing age, decreasing BMI, and fat percentage (p < 0.001, Cochran Armitage test). Multivariate logistic regression analysis revealed sarcopenia's risk factors, including older age, male sex, lower levels of BMI, TC, and TG, and higher levels of LDL and HCY (p < 0.05). The sarcopenia risk prediction model showed the risk prediction value of sarcopenia, with the highest area under the receiver operating curve (AUC) of 0.775. Our study provided thorough insight into the risk factors associated with sarcopenia. It demonstrated that an increase in lipid metabolism-related parameters (BMI, TG, TC), within normal reference ranges, may be protective against sarcopenia. The present study can illuminate the direction and significance of lipid metabolism-related factors in preventing sarcopenia.

PubMed Disclaimer

Conflict of interest statement

The authors declare no competing interests.

Figures

Figure 1
Figure 1
Sarcopenia prevalence (a) All patients. (b) Assessment of sarcopenia by age. (c) Assessment of sarcopenia by BMI quartile. Q1, first quartile, < 20.8 kg/m2; Q2, second quartile, 20.8–23.3 kg/m2; Q3, third quartile, 23.3–25.8 kg/m2; Q4, fourth quartile, > 25.8 kg/m2. (d) Assessment of sarcopenia by fat percentage quartile. Q1, < 27.7%; Q2, 27.7–33.1%; Q3, 33.1–37.5%; Q4, > 37.5%.
Figure 2
Figure 2
Sarcopenia prevalence (a) Assessment of sarcopenia by TC quartile. Q1, < 3.55 mmol/L; Q2, 3.55–4.13 mmol/L; Q3, 4.13–4.81 mmol/L; Q4, > 4.81 mmol/L. (b) Assessment of sarcopenia by TG quartile. Q1, < 0.80 mmol/L; Q2, 0.80–1.07 mmol/L; Q3, 1.07–1.55 mmol/L; Q4, > 1.55 mmol/L. (c) Assessment of sarcopenia by HDL quartile. Q1, < 1.14 mmol/L; Q2, 1.14–1.33 mmol/L; Q3, 1.33–1.51 mmol/L; Q4, > 1.51 mmol/L. (d) Assessment of sarcopenia by LDL quartile. Q1, < 1.97 mmol/L; Q2, 1.97–2.45 mmol/L; Q3, 2.45–3.04 mmol/L; Q4, > 3.04 mmol/L.
Figure 3
Figure 3
ROC curve of sarcopenia risk prediction model. (a) LR; (b) SVM; (c) KNN; (d) XGboost.

Similar articles

Cited by

References

    1. Cruz-Jentoft AJ, Sayer AA. Sarcopenia. Lancet. 2019;393(10191):2636–2646. doi: 10.1016/S0140-6736(19)31138-9. - DOI - PubMed
    1. Chen LK, Woo J, Assantachai P, Auyeung TW, Chou MY, Iijima K, et al. Asian Working Group for Sarcopenia: 2019 Consensus update on sarcopenia diagnosis and treatment. J. Am Med Dir Assoc. 2020;21(3):300–7.e2. doi: 10.1016/j.jamda.2019.12.012. - DOI - PubMed
    1. Ren X, Zhang X, He Q, Du L, Chen K, Chen S, et al. Prevalence of sarcopenia in Chinese community-dwelling elderly: a systematic review. BMC Public Health. 2022;22(1):1702. doi: 10.1186/s12889-022-13909-z. - DOI - PMC - PubMed
    1. Mok A, Khaw KT, Luben R, Wareham N, Brage S. Physical activity trajectories and mortality: population based cohort study. Bmj. 2019;365:l2323. doi: 10.1136/bmj.l2323. - DOI - PMC - PubMed
    1. Kelly RS, Kelly MP, Kelly P. Metabolomics, physical activity, exercise and health: A review of the current evidence. Biochim Biophys Acta Mol Basis Dis. 2020;1866(12):165936. doi: 10.1016/j.bbadis.2020.165936. - DOI - PMC - PubMed

Publication types